8-K/A
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-17-011917
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading cerc-form8xkremoscatoee.htm…